What is the service/product?
IDM RPT for Advertising Content and Design is a cloud-based experimentation platform that applies Randomized Parallel Trial (RPT) methodology—the gold standard in scientific testing—to marketing and design. It enables marketers to test multiple ad creatives or messages simultaneously and identify which version performs best using real behavioral data from live audiences.
Who needs it?
Marketing teams seeking to validate creative decisions, agencies and startups optimizing digital campaigns before scaling spend, and brands aiming to replace guesswork with experimental evidence need this service.
What problem does it solve?
It solves the problem that intuition is no longer enough in marketing, where every image, word, and color can change results. The service replaces guesswork with experimental evidence to determine which creative truly works.
How does IDM deliver it?
IDM has automated and simplified the advanced RPT methodology into a cloud-based experimentation platform. It measures real behavioral impact in just a few days at a fraction of traditional research cost, with complete scientific-grade trials within 5 days.
What are the deliverables?
The deliverables include evidence-based results comparing multiple ad designs or messages under identical conditions, identifying which version drives the highest clicks, conversions, or engagement using real behavioral data from live audiences.
When should an organization use it?
An organization should use it when marketing teams need to validate creative decisions, when agencies or startups are optimizing digital campaigns before scaling spend, or when brands want to replace guesswork with experimental evidence.
What alternatives exist?
Alternatives include traditional A/B testing and traditional research methods, which may be slower or more costly compared to IDM's automated RPT platform.
What differentiates IDM?
IDM differentiates by applying Randomized Parallel Trial methodology—originally used in clinical research to measure drug effectiveness—and automating it into an accessible cloud platform. It offers fast 5-day turnaround, low cost, and evidence-based strategy, translating scientific research methods into accessible business tools.